companydata.dkRenescience A/S: Financial statements 2025
CVR: 31846803
Renescience A/S (CVR 31846803) has filed annual accounts for 2025. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. That is a decrease of 99.8% compared with the year before. The profit margin was -2,399,700%. Equity amounted to DKK 73,470,000. The solvency ratio was 90.4%. The company had 1,000 employees in the financial year.
- Revenue
- 21,000 kr.
- Gross Profit
- -5,425,000 kr.
- Profit/Loss
- -503,937,000 kr.
- Equity
- 73,470,000 kr.
- Total Assets
- 81,310,000 kr.
- Employees
- 1,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | 21 t. | -5.4 mio. | -503.9 mio. | 73.5 mio. | 1000 |
| 2024 | 10.8 mio. | -15.4 mio. | -23.9 mio. | 7.4 mio. | 1000 |
| 2023 | 10.4 mio. | -13.5 mio. | -194.6 mio. | -11.7 mio. | 0 |
| 2022 | 10.8 mio. | -10.9 mio. | -13.3 mio. | 183 mio. | 0 |
| 2021 | 8 mio. | -11.4 mio. | -8.3 mio. | 22.8 mio. | - |
Find more companies like Renescience A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2025
Renescience A/S has published its annual report for 2024. Revenue came to DKK 10,836,000, and the net result was DKK -23,904,000.
As of February 27, 2025, Ole Thomsen has joined the board of directors of Renescience A/S.
As of February 27, 2025, Jens Grymer has joined the board of directors of Renescience A/S.
As of February 27, 2025, Mikael Brandt has left the board of directors of Renescience A/S.
As of February 26, 2025, Ole Thomsen has left the board of directors of Renescience A/S.
About Renescience A/S
Renescience A/S is a Danish company of the type Aktieselskab based in Fredericia, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Lars Holm Lerke-Møller. The company is owned by Ørsted New Bio Solutions Holding A/S. In 2025, the company reported revenue of DKK 21,000 and a net result of DKK -503,937,000 compared with DKK -23,904,000 the year before. Equity amounted to DKK 73,470,000.